Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Double-chamber osmotic pump type glipizide controlled release tablet and industrial production method

A technique for glipizide and a production method, which is applied in the field of dual-chamber osmotic pump type glipizide controlled-release tablets and industrialized production, can solve problems such as affecting product quality and yield, affecting product quality, and being difficult to clean, and achieving The effect of reducing equipment investment, eliminating organic residues and improving production efficiency

Inactive Publication Date: 2019-10-25
淄博万杰制药有限公司
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

It is greatly affected by light and heat conditions. Once the temperature exceeds 40°C, it will undergo obvious deterioration. In the production process, the drying temperature rises, the mechanical friction during tablet compression, and the temperature during coating can easily exceed this temperature. It is also prone to problems during long-term use and storage
[0010] 2. Due to the relatively large molecular weight of PEO, the speed of hydration and emulsification with water in the body is relatively slow, resulting in a long "time lag" for the drug to take effect, and it is difficult to take effect quickly after oral administration, which affects the drug's action time
And this property also makes it difficult to clean during the production process, which is not conducive to the maintenance of the production environment.
[0011] 3. The granulation method often used in the production process is generally wet granulation or dry granulation. When using wet granulation, due to its thermal instability and low drying temperature, it is easy to cause organic residues; when using dry granulation, industrialization During production, the equipment runs for a long time, and the temperature of the machine will rise significantly, and the material at the friction point of the mechanical transmission will be partially denatured, showing a "plastic"-like resin, which will affect the product quality and yield.
[0015] Because osmotic pump tablets need to be double-layered and double-colored, and the granules made by dry granulation or wet granulation, the colorant in it cannot be cured, and it is easy to scatter or adhere to the equipment. It is prone to color mixing of double-layer sheets, which affects product quality and interferes with the identification of subsequent laser drilling
[0016] 4. Organic residues
However, in the process of melting the small holes, a hard shell formed by melting the material will appear on the surface of the hole. When released in the body, the internal pressure formed by the propellant must first push away the hard shell to release smoothly. Aggravated the "time lag" phenomenon and delayed the onset time of drugs
In addition, the use of high-power lasers has relatively obvious laser intensity attenuation. In the process of industrial production, it is easy to cause batch-to-batch differences and unstable quality problems. Moreover, lasers with a power above 70W are subject to control when imported, equipment and equipment. There are certain obstacles in the subsequent maintenance and replacement of accessories

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Double-chamber osmotic pump type glipizide controlled release tablet and industrial production method
  • Double-chamber osmotic pump type glipizide controlled release tablet and industrial production method
  • Double-chamber osmotic pump type glipizide controlled release tablet and industrial production method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0109] The double-chamber osmotic pump type glipizide controlled-release tablet of the present invention is composed of a drug layer, a push layer, a rigid semipermeable membrane, drug release holes and a moisture-proof layer; the drug layer uses polyethylene glycol 6000 as a carrier, The hot-melt method was used for granulation without using organic solvents, and the double-chamber osmotic pump glipizide controlled-release tablets were prepared by drawing circular holes with a low-power laser.

[0110] The drug layer is prepared from glipizide, lactose, polyvinylpyrrolidone K90, polyethylene glycol 6000 and magnesium stearate.

[0111] The push layer is prepared from sodium alginate, sodium chloride, polyethylene glycol 6000, iron oxide red, polyvinylpyrrolidone K90 and magnesium stearate.

[0112] Rigid semipermeable membranes are prepared from cellulose diacetate, polyethylene glycol 1500, and acetone.

[0113] The moisture-proof layer is prepared from hydroxypropyl methyl...

Embodiment 2

[0137] The double-chamber osmotic pump type glipizide controlled-release tablet of the present invention is composed of a drug layer, a push layer, a rigid semipermeable membrane, drug release holes and a moisture-proof layer; the drug layer uses polyethylene glycol 6000 as a carrier, The hot-melt method was used for granulation without using organic solvents, and the double-chamber osmotic pump glipizide controlled-release tablets were prepared by drawing circular holes with a low-power laser.

[0138] The drug layer is prepared from glipizide, lactose, polyvinylpyrrolidone K90, polyethylene glycol 6000 and magnesium stearate.

[0139] The push layer is prepared from sodium alginate, sodium chloride, polyethylene glycol 6000, iron oxide red, polyvinylpyrrolidone K90 and magnesium stearate.

[0140] Rigid semipermeable membranes are prepared from cellulose diacetate, polyethylene glycol 1500, and acetone.

[0141] The moisture-proof layer is prepared from hydroxypropyl methyl...

Embodiment 3

[0166] The double-chamber osmotic pump type glipizide controlled-release tablet of the present invention is composed of a drug layer, a push layer, a rigid semipermeable membrane, drug release holes and a moisture-proof layer; the drug layer uses polyethylene glycol 6000 as a carrier, The hot-melt method was used for granulation without using organic solvents, and the double-chamber osmotic pump glipizide controlled-release tablets were prepared by drawing circular holes with a low-power laser.

[0167] The drug layer is prepared from glipizide, lactose, polyvinylpyrrolidone K90, polyethylene glycol 6000 and magnesium stearate.

[0168] The push layer is prepared from sodium alginate, sodium chloride, polyethylene glycol 6000, iron oxide red, polyvinylpyrrolidone K90 and magnesium stearate.

[0169] Rigid semipermeable membranes are prepared from cellulose diacetate, polyethylene glycol 1500, and acetone.

[0170] The moisture-proof layer is prepared from hydroxypropyl methyl...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of glipizide controlled release tablets, and particularly relates to a double-chamber osmotic pump type glipizide controlled release tablet and an industrial production method. The double-chamber osmotic pump type glipizide controlled release tablet consists of a drug layer, a propelling layer, a rigid semi-permeable membrane, a drug release small holeand a moisture-proof layer; the drug layer takes polyethylene glycol 6000 as a carrier, granulation is carried out by a hot melting method, an organic solvent is not used, and low-power laser round punching is carried out to prepare the double-chamber osmotic pump type glipizide controlled release tablet. The double-chamber osmotic pump type glipizide controlled release tablet and the industrial production method have the advantages of simple granulation process, less equipment investment, high production efficiency, low energy consumption and suitability for industrial production. The produced controlled release tablet is good in stability and convenient to store and transport; organic solvent residues are completely avoided in a granulation process; in a double-layer tabletting process,the technical problem of color mixing is solved, the requirement on equipment performance is lowered, and the service life of the equipment is prolonged.

Description

technical field [0001] The invention belongs to the technical field of glipizide controlled-release tablets, and in particular relates to a double-chamber osmotic pump type glipizide controlled-release tablet and an industrial production method. Background technique [0002] The osmotic pump type controlled-release tablet fully mixes the drug and the osmotic solubilizing substance, and makes granules according to various granulation methods, and adopts double-layer compression to make a double-layer tablet core, one of which is a drug-containing layer, and the other is a drug-containing layer. Push layer, and then coat the tablet core with cellulose acetate to form a semi-permeable rigid outer membrane, and finally a drug release hole is made on the membrane by a laser. After the patient takes it, due to the penetration in the tablet core The active substance forms a high osmotic pressure, prompting water to enter the tablet from the semi-permeable membrane, and the propella...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/44A61K9/36A61K9/24A61K31/64A61K47/10A61K47/32
CPCA61K31/64A61K9/2086A61K9/2077A61K9/2866A61K9/2027A61K9/2031
Inventor 潘炳旗王磊李艳孙国庆刘继栋宋雁鹏李秀峰
Owner 淄博万杰制药有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products